Cognition Therapeutics, Inc.
CGTX • NASDAQ • Stock Fundamentals
Cognition Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lisa Ricciardi, with a market cap of $107.4M.
Market Cap$107.4M
Employees25.0
CEOLisa Ricciardi
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
CGT
Cognition Therapeutics, Inc. FAQ
Common questions about Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. (CGTX) has a market capitalization of $107.4M and trades on NASDAQ.
Cognition Therapeutics, Inc. has approximately 25 employees.